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Background: The major problems of commonly used drug-eluting stents were strong peri-stent inflammatory response and delayed arterial 
healing. The aim of this study was to examine the anti-proliferative and anti-inflammatory effects and arterial healing of ramiprilat-coated stent in a 
porcine coronary overstretch restenosis model.
Methods: Pigs were randomized into two groups in which the coronary arteries (16 pigs, 16 coronaries in each group) had either a ramiprilat-
coated MAC stent or control MAC stent (AMG, Munich, Germany). Stents were deployed with oversizing (stent/artery ratio 1.3:1) in porcine coronary 
arteries, and histopathologic analysis was assessed at 28 days after stenting.
Results: There were no significant differences in the neointima area normalized to injury score and inflammation score between the two groups 
(1.58±0.43, 1.60±0.39 in ramiprilat stent group vs. 1.60±0.57, 1.62±0.49 in control stent group, respectively). In neointima, most inflammatory 
cells were lymphohistiocytes. Overall, significant positive correlations were found between the lymphohistiocyte count and the neointima area 
(r=0.567, p<0.001) and between the lymphohistiocyte count and the percent area stenosis (r=0.478, p<0.001). Lymphohistiocyte count (170±121 
cells vs. 162±83 cells) and fibrin scores (0.15±0.06 vs. 0.17±0.07, p=0.8) were low in ramiprilat stent group as same as those in control group. 
There was a strong trend of smaller neointima area (1.06±0.51 mm2 vs. 1.28±0.35 mm2, p=0.083) and percent area stenosis (18.9±8.7% vs. 
22.8±7.2%, p=0.088) in the ramiprilat stent group compared with control group.
Conclusions: Ramiprilat-coated stent showed a good inhibitory effect on neointimal hyperplasia without differences in inflammatory reaction and 
arterial healing compared with bare-metal stent in a porcine coronary restenosis model.
